M. Vidal
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- Antimicrobial Resistance in Staphylococcus
- Rehabilitation top 10%
- Wound Healing and Treatments
Papers in
-
- Streptococcal Infections and Treatments 5
- Aging, Health, and Disability 3
-
- Antimicrobial Resistance in Staphylococcus 5
- Antifungal resistance and susceptibility 3
- Co-authors
- O. Lesens (17 shared papers)J. Beytout (8 shared papers)H. Laurichesse (9 shared papers)Natacha Mrozek (10 shared papers)Igor Tauveron (4 shared papers)F. Desbiez (4 shared papers)Stéphane Descamps (3 shared papers)Frédéric Robin (2 shared papers)
In The Last Decade
M. Vidal
34 papers receiving 469 citations
Peers
Comparison fields: 5 of 87
- Infectious Diseases 133
- Rehabilitation 45
- Endocrinology, Diabetes and Metabolism 109
- Emergency Medical Services 33
- Neurology 52
Countries citing papers authored by M. Vidal
This map shows the geographic impact of M. Vidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Vidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Vidal more than expected).
Fields of papers citing papers by M. Vidal
This network shows the impact of papers produced by M. Vidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Vidal. The network helps show where M. Vidal may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Vidal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 75 | |
| 2 | 2020 | 54 | |
| 3 | 2010 | 36 | |
| 4 | 2021 | 36 | |
| 5 | 2019 | 33 | |
| 6 | 2007 | 30 | |
| 7 | 2022 | 29 | |
| 8 | 2016 | 25 | |
| 9 | 2009 | 18 | |
| 10 | 2005 | 17 | |
| 11 | 2005 | 15 | |
| 12 | 2013 | 12 | |
| 13 | 2012 | 11 | |
| 14 | 2017 | 11 | |
| 15 | 2009 | 10 | |
| 16 | 2018 | 9 | |
| 17 | 2016 | 8 | |
| 18 | 2014 | 7 | |
| 19 | 2006 | 6 | |
| 20 | 2021 | 6 |
About M. Vidal
M. Vidal is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases, Epidemiology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 38 papers that have together received 487 indexed citations. Recurring topics across this work include Streptococcal Infections and Treatments (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Diabetic Foot Ulcer Assessment and Management (4 papers), Aging, Health, and Disability (3 papers), Antifungal resistance and susceptibility (3 papers), Infective Endocarditis Diagnosis and Management (3 papers), Fungal Infections and Studies (2 papers) and Plant Pathogens and Fungal Diseases (2 papers). The work is most often cited by research in Infectious Diseases (133 citations), Rehabilitation (45 citations), Endocrinology, Diabetes and Metabolism (109 citations), Emergency Medical Services (33 citations) and Neurology (52 citations). M. Vidal has collaborated with scholars based in France, Chile and Spain. Frequent co-authors include O. Lesens, J. Beytout, H. Laurichesse, Natacha Mrozek, Igor Tauveron, F. Desbiez, Stéphane Descamps, Frédéric Robin, C. Auméran and Christiane Forestier. Their work appears in journals such as Clinical Microbiology and Infection, Diagnostic Microbiology and Infectious Disease, European Journal of Clinical Microbiology & Infectious Diseases, Journal of Clinical Microbiology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.